All News

ASRS launches See for a Lifetime See a Retina Specialist education initiative

American Society of Retinal Specialists program to drive awareness and action around retinal diseases that put millions at risk for blindness.

Virtual training takes on sight-threatening condition caused by diabetes

Orbis, with support from FedEx, is offering training that will develop ophthalmologists’ skills to treat diabetic retinopathy in China.

Horizon Therapeutics releases Phase 2/3 results for inebilizumab-cdon

The company announced that inebilizumab-cdon produces rapid and sustained B-cell depletion in African Americans with neuromyelitis optica spectrum disorder.

Glaukos unveils licensing agreement for compounds that target Demodex mites

September 20, 2021

Glaukos has entered into a licensing agreement with Attillaps Holdings Inc., giving it an exclusive license to research, develop, manufacture and commercialize Attillaps’ proprietary library of investigational pharmaceutical compounds that target the eradication of Demodex mites.